Search Results

Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival

Authors: Saif, Muhammad Wasif; Hashmi, Sharukh; Bell, Diana; Diasio, Robert B

Source: Expert Opinion on Drug Safety, Volume 8, Number 5, September 2009 , pp. 507-514(8)

Publisher: Informa Healthcare

Functional analysis of pyrimidine biosynthesis enzymes using the anticancer drug 5-fluorouracil in Caenorhabditis elegans

Authors: Kim, Seongseop; Park, Dae-Hun; Kim, Tai Hoon; Hwang, Moogak; Shim, Jaegal

Source: FEBS Journal, Volume 276, Number 17, September 2009 , pp. 4715-4726(12)

Publisher: Blackwell Publishing

Expression of Thymidine Phosphorylase in Primary Colorectal Cancer and Liver Metastasis— Relationship between mRNA Levels in Cancer Cells and Protein Levels in Cancerous Tissue

Authors: Ishibashi, Keiichiro; Sobajima, Jun; Ishiguro, Toru; Okada, Norimichi; Miyazaki, Tatsuya; Yokoyama, Masaru; Ishida, Hideyuki

Source: Japanese Journal of Cancer and Chemotherapy, Volume 36, Number 3, March 2009 , pp. 425-429(5)

Publisher: Sunmedia

Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer

Authors: Andreetta, C.; Puppin, C.; Minisini, A.; Valent, F.; Pegolo, E.; Damante, G.; Di Loreto, C.; Pizzolitto, S.; Pandolfi, M.; Fasola, G.; Piga, A.; Puglisi, F.

Source: Annals of Oncology, Volume 20, Number 2, 14 February 2009 , pp. 265-271(7)

Publisher: Oxford University Press

Comparison of 5-Fluorouracil-related Gene Expression Levels Between Adenocarcinomas and Squamous Cell Carcinomas of the Lung

Authors: Ishihama, Hiromi; Chida, Masayuki; Araki, Osamu; Karube, Yoko; Seki, Norio; Tamura, Motohiko; Umezu, Hideo; Honma, Koichi; Masawa, Nobuhide; Miyoshi, Shinichiro

Source: Japanese Journal of Clinical Oncology, Volume 39, Number 1, 24 January 2009 , pp. 33-36(4)

Publisher: Oxford University Press

An investigation of the kinetic and anti-angiogenic properties of plant glycoside inhibitors of thymidine phosphorylase

Authors: Hussain, S.; Gaffney, J.; Ahmed, N.; Slevin, M.; Iqbal Choudhary, M.; Ahmad, V. U.; Qasmi, Z.; Abbasi, M. A.

Source: Journal of Asian Natural Products Research, Volume 11, Number 2, February 2009 , pp. 159-167(9)

Publisher: Taylor and Francis Ltd

Molecular Markers for Individualized Therapy in Colorectal Cancer: Progress Towards a Pharmacogenomics Array

Authors: Ahn, S.; Hussain, F.; Dragovich, T.

Source: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacog, Volume 7, Number 1, March 2009 , pp. 70-80(11)

Publisher: Bentham Science Publishers

Unchanged thymidine triphosphate pools and thymidine metabolism in two lines of thymidine kinase 2-mutated fibroblasts

Authors: Frangini, Miriam; Rampazzo, Chiara; Franzolin, Elisa; Lara, Mari-Carmen; Vilà, Maya R.; Martí, Ramon; Bianchi, Vera

Source: FEBS Journal, Volume 276, Number 4, February 2009 , pp. 1104-1113(10)

Publisher: Blackwell Publishing

2-Deoxy-D-Ribose, a Downstream Mediator of Thymidine Phosphorylase, Regulates Tumor Angiogenesis and Progression

Authors: Nakajima, Yuichi; Madhyastha, Radha; Maruyama, Masugi

Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry, Volume 9, Number 2, February 2009 , pp. 239-245(7)

Publisher: Bentham Science Publishers

Proteomic analysis of metastatic laryngeal squamous cell carcinoma: Abstracts of the Otorhinolaryngological Research Society Meeting Autumn Meeting

Authors: Goodyear, P.W.A.; Boyd, M.T.; Jenkins, R.; Hamlett, J.; Kitteringham, N.; Jones, T.M.

Source: Clinical Otolaryngology, Volume 33, Number 6, December 2008 , pp. 642-642(1)

Publisher: Blackwell Publishing

Substrate Specificity of Thymidine Phosphorylase of E. Coli: Role of Hydroxyl Groups

Authors: Panova, Natalya; Alexeev, Cyril; Polyakov, Konstantin; Gavryushov, Sergei; Kritzyn, Anatoliy; Mikhailov, Sergey

Source: Nucleosides, Nucleotides & Nucleic Acids, Volume 27, Number 12, November 2008 , pp. 1211-1214(4)

Publisher: Taylor and Francis Ltd

Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas

Authors: Stoebner, Pierre E.; Le Gallic, Lionel; Berthe, Marie L.; Boulle, Nathalie; Lallemant, Benjamin; Marque, Myriam; Gaspard, Catherine; Delfour, Christophe; Lavabre-Bertrand, Thierry; Martinez, Jean; Meunier, Laurent

Source: Experimental Dermatology, Volume 17, Number 11, November 2008 , pp. 908-915(8)

Publisher: Blackwell Publishing

Phase I Clinical Study of Three Times a Day Oral Administration of TAS-102 in Patients with Solid Tumors

Authors: Overman, Michael; Kopetz, Scott; Varadhachary, Gauri; Fukushima, Masakazu; Kuwata, Keizo; Mita, Akira; Wolff, Robert; Hoff, Paulo; Xiong, Henry; Abbruzzese, James

Source: Cancer Investigation, Volume 26, Number 8, October 2008 , pp. 794-799(6)

Publisher: Informa Healthcare

Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer

Authors: Astrup Jensen, Søren; Vainer, Ben; Janet Witton, Caroline; Trøst Jørgensen, Jan; Benn Sørensen, Jens

Source: Acta Oncologica, Volume 47, Number 6, August 2008 , pp. 1054-1061(8)

Publisher: Informa Healthcare

The Role of Platelet-Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase in Tumor Behavior

Authors: Bijnsdorp, I. V.; de Bruin, M.; Laan, A. C.; Fukushima, M.; Peters, G. J.

Source: Nucleosides, Nucleotides & Nucleic Acids, Volume 27, Numbers 6-7, June 2008 , pp. 681-691(11)

Publisher: Taylor and Francis Ltd

Candidate mechanisms for capecitabine-related hand-foot syndrome

Authors: Milano, Gérard; Etienne-Grimaldi, Marie-Christine; Mari, Mireille; Lassalle, Sandra; Formento, Jean-Louis; Francoual, Mireille; Lacour, Jean-Philippe; Hofman, Paul

Source: British Journal of Clinical Pharmacology, Volume 66, Number 1, July 2008 , pp. 88-95(8)

Publisher: Blackwell Publishing

Recent advances in the molecular diagnosis and prognosis of colorectal cancer

Author: Huerta, Sergio

Source: Expert Review of Molecular Diagnostics, Volume 8, Number 3, May 2008 , pp. 277-288(12)

Publisher: Expert Reviews

A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma

Authors: Lee, Jeeyun; Im, Young-Hyuck; Cho, Eun; Hong, Yong; Lee, Hyo; Kim, Hyo; Kim, Mi-Jin; Kim, Kwhanmien; Kang, Won; Park, Keunchil; Shim, Young

Source: Cancer Chemotherapy and Pharmacology, Volume 62, Number 1, June 2008 , pp. 77-84(8)

Publisher: Springer

Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity

Authors: Guarcello, Vincenzo; Blanquicett, Carmelo; Naguib, Fardos; el Kouni, Mahmoud

Source: Cancer Chemotherapy and Pharmacology, Volume 62, Number 1, June 2008 , pp. 85-96(12)

Publisher: Springer

A Carboxylesterase 2 Gene Polymorphism as Predictor of Capecitabine on Response and Time to Progression

Authors: Ribelles, N.; Lopez-Siles, J.; Sanchez, A.; Gonzalez, E.; Sanchez, M. J.; Carabantes, F.; Sanchez-Rovira, P.; Marquez, A.; Duenas, R.; Sevilla, I.; Alba, E.

Source: Current Drug Metabolism, Volume 9, Number 4, May 2008 , pp. 336-343(8)

Publisher: Bentham Science Publishers